Atlas market file · Equity · Europe
L'OrealOR
L'Oreal (OR) has a latest verified close of 374.70, up 1.59%, dated 24 Jul 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- EURONEXT symbol identity
- Chart rail
- TradingView
- File state
- Public profile
Atlas Pro artifact
OR Market Snapshot PDF
The latest snapshot audit passed. Atlas checks entitlement and evidence again when the PDF is requested.
A retained research PDF is available to Atlas Pro accounts. Snapshot checks remain separate.
OR public profile
Listed company. L'Oreal is connected to current market context, cited company sources and its retained research file.
L'Oreal trades as OR on EURONEXT. L'Oreal (OR) has a latest verified close of 374.70, up 1.59%, dated 24 Jul 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. OR stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
Market Wit preview
The board of L’Oréal, the world’s largest beauty house, just proposed the same €7.20 dividend shareholders received in 2025, proving once again that even the French are allergic to nominal cuts. Shareholders who bother to register their shares in the corporate books get a 10 % boost, a reward so niche it makes you wonder whether the board is courting the 0.01 % who still hold paper certificates or simply trolling the rest of us with a loyalty scheme that measures affection in basis points. The dividend is slated to sail through the AGM on 24 April 2026, so unless the French government suddenly slaps a surtax on dividends between now and then, expect the payout to land in April like clockwork. (source: Official issuer...
Run the full workstation report for the complete source rail, saved history, export controls, and the full Market Wit file for OR.
What changed for L'Oreal today
L’Oréal’s annual report for 2025 quietly confirms the company is still printing euros at scale: e-commerce alone delivered €13 billion in sales, while total revenue grew on the back of skincare and the Consumer Products Division, each contributing 37 % of the top line. The dividend is set at €7.20 for the AGM on 24 April 2026, with registered shareholders receiving a 10 % top-up-an incentive so rarefied it reads like a loyalty programme for people who still keep share certificates in a drawer. (source: Official issuer, https://www.loreal-finance.com/system/files/2026-04/LOREAL_RA_2025_EXE_UK_260313_OPT_PMS%20345C%2025pc_v3_05.pdf)
The company markets itself as a science-led beauty empire, and its research portals are stuffed with papers on “game-changing foresights,” “transparency,” and “tomorrow’s beauty.” Yet the filing’s numbers tell a simpler story: the business still runs on shelves, counters, and online carts, and the margin-rich skincare aisle remains the beating heart of the P&L. Meanwhile, the Consumer Products Division-home to brands like 3CE-keeps the tills ringing, while Europe stubbornly contributes 34 % of sales. (source: Official issuer, https://www.loreal-finance.com/system/files/2026-04/LOREAL_RA_2025_EXE_UK_260313_OPT_PMS%20345C%2025pc_v3_05.pdf)
L’Oréal’s operating segments are colour-coded into Consumer Products (37 %), Europe (34 %), and Skincare (37 %), a neat symmetry that masks a less tidy reality: the group still leans on traditional channels even as e-commerce grabs every extra basis point it can. The annual report cheerfully notes that e-commerce’s share of sales rose by 200 basis points, which is another way of saying the high-margin web shelf is eating the low-margin counter space while the company smiles and calls it “strategic acceleration.” (source: Official issuer, https://www.loreal-finance.com/system/files/2026-04/LOREAL_RA_2025_EXE_UK_260313_OPT_PMS%20345C%2025pc_v3_05.pdf)
To track the daily tape, head to TradingView where EURONEXT:OR shows the regional route for L’Oréal S.A. on Euronext Paris; the chart is a live feed of the issuer’s daily price formation, not a crystal ball. The rail does not pretend to forecast levels, only to present the source-backed market data as supplied. (source: TradingView, https://www.tradingview.com/chart/?symbol=EURONEXT%3AOR)
What changed this week: the dividend proposal is locked in, e-commerce’s share of sales continues to climb, and the skincare aisle remains the group’s largest single revenue engine. What remains unproven: the company does not disclose operating income or free cash flow for the period, nor does it reveal share-buyback volume or net-income reconciliation in the cited filings, so the quantum of cash returned to equity holders beyond the dividend cannot be quantified from the supplied evidence. (source: Official issuer, https://www.loreal-finance.com/system/files/2026-04/LOREAL_RA_2025_EXE_UK_260313_OPT_PMS%20345C%2025pc_v3_05.pdf)
Evidence that would deepen the file: a segment-level breakdown of operating profit, quarterly cash-flow details, and any disclosure on share-buyback authorisations or dilution for the current fiscal year. Until then, the story is cash, counters, and cupped palms at the beauty counter. (source: Official issuer, https://www.loreal-finance.com/eng)
Sources & evidence · 9 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-2.10% over the window).
Source rail: Yahoo Finance chart API (OR.PA). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for OR. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
Open an Atlas research path on OR
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep OR research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
OR FAQ
What is L'Oreal (OR)?L'Oreal (OR) has a latest verified close of 374.70, up 1.59%, dated 24 Jul 2026. Use this page to check the price chart, company context, source-backed updates, risks...
L'Oreal (OR) has a latest verified close of 374.70, up 1.59%, dated 24 Jul 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for OR?L'Oreal (OR) has a latest verified close of 374.70, up 1.59%, dated 24 Jul 2026. It brings the latest available chart, company context, cited sources, risks and the...
L'Oreal (OR) has a latest verified close of 374.70, up 1.59%, dated 24 Jul 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. OR stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the OR page updated?The OR public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The OR public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for OR?The OR file starts with EURONEXT symbol identity and TradingView EURONEXT:OR. The page separates verified market context from company evidence and shows open evidence...
The OR file starts with EURONEXT symbol identity and TradingView EURONEXT:OR. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on OR?Yes. The workstation can open OR, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open OR, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this OR page investment advice?No. The OR page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of...
No. The OR page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-07-24. Browse FreedomCore Atlas research notes →
OR
Equity · evidence first